References

AddingtonJ: Group treatment for smoking cessation with schizophrenia. Psychiatr Serv 49:925-928, 1998

Addington J, el-Guebaly N, Addington D, et al: Readiness to stop smoking in schizophrenia. Can J Psychol 42:49-52, 1997 Addington J, el-Guebaly N, Campbell W, et al: Smoking cessation treatment for patients with schizophrenia. AmJ Psychiatry 155:974-976, 1998 Addington J, el-Guebaly N, Duchak V, et al: Using measures of readiness to change in individuals with schizophrenia. Am J Drug Alcohol Abuse 25:151161, 1999

Adler LE, Hoffer LD, Wiser A, et al: Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 150:1856-1861, 1993

Adler LE, Hoffer LD, Waldo M, et al: Schizophrenia, sensory gating and nicotinic receptors. Schizophr Bull 24:189-202, 1998 Allebeck P: Schizophrenia: a life-shortening disease. Schizophr Bull 15:81-89, 1989

American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000

Arnsten AF: Through the looking glass: differential noradrenergic modulation of prefrontal cortical function. Neural Plast 7:133-146, 2000 Balfour DJK, Fagerstrom KO: Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Pharmacol Ther 72:5181, 1996

Chong SA, Choo HL: Smoking among Chinese patients with schizophrenia. Aust

N Z J Psychiatry 30:350-353, 1996 Collins AC, Luo Y, Selvang S, et al: Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion. J Pharmacol Exp Ther 271:125-133, 1994 Dalack GW, Meador-Woodruff JH: Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literature. Schizophr Res 22:133-141, 1996

Dalack GW, Meador-WoodruffJH: Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia. Nicotine Tob Res 1:53-57, 1999 Dalack GW, Healy DJ, Meador-WoodruffJH: Nicotine dependence and schizophrenia: clinical phenomenon and laboratory findings. Am J Psychiatry 155:1490-1501, 1998 Dalack GW, Becks L, Hill E, et al: Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology 21:195202, 1999

de LeonJ, Dadvand M, Canuso C, et al: Schizophrenia and smoking: an epidemiological survey in a state hospital. AmJ Psychiatry 152:453-455, 1995 Decina P, Caracci G, Sandik R, et al: Cigarette smoking and neuroleptic-induced parkinsonism. Biol Psychiatry 28:502-508, 1990 Diwan A, Castine M, Pomerleau CS, et al: Differential prevalence of cigarette smoking in patients with schizophrenia vs. mood disorders. Schizophr Res 33:113-118, 1998

el-Guebaly N, Hodgins D: Schizophrenia and substance abuse: prevalence issues.

CanJ Psychiatry 37:704-710, 1992 Evins AE, Mays VK, Rigotti NA, et al: A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine Tob Res 3:397-403, 2001 Fowler JS, Volkow ND, Wang G-J, et al: Inhibition of monoamine oxidase B in the brains of smokers. Nature 379:733-736, 1996a Fowler JS, Volkow ND, Wang G-J, et al: Brain monoamine oxidase A: inhibition by cigarette smoke. Proc Natl Acad Sci U S A 93:14065-14069, 1996b Freedman R, Coon H, Myles-Worsley M, et al: Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A 94:587-592, 1997

George TP, Vessicchio JC: Nicotine addiction and schizophrenia. Psychiatric

Times 18:39-42, 2001 George TP, Sernyak MJ, Ziedonis DM, et al: Effects of clozapine on smoking in chronic schizophrenic outpatients. J Clin Psychiatry 56:344-346, 1995 George TP, Verrico CD, Roth RH: Effects of repeated nicotine pre-treatment on mesoprefontal dopaminergic and behavioral responses to acute footshock stress. Brain Res 801:36-49, 1998 George TP, Zeidonis DM, Feingold A, et al: Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry 157:1835-1842, 2000a George TP, Verrico CD, Xu L, et al: Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: evidence for opioid mechanisms. Neuropsychopharmacology 23:79-88, 2000b George TP, Verrico CD, Picciotto MR, et al: Nicotinic modulation of mesoprefrontal dopamine systems: pharmacologic and neuroanatomic characterization. J Pharmacol Exp Ther 295:58-66, 2000c George TP, Vessicchio JC, Termine A, et al: A laboratory study of nicotinic receptor mechanisms and cognitive function in schizophrenia. Paper presented at the 40th annual meeting of the American College of Neuropsychopharmacol-ogy, Waikoloa, HI, 2001 George TP, Vessicchio JC, Termine A, et al: Effects of smoking abstinence on visu-ospatial working memory function in schizophrenia. Neuropsychopharmacology 26:75-85, 2002a George TP, Vessicchio JC, Termine A, et al: A placebo-controlled study of bupropion for smoking cessation in schizophrenia. Biol Psychiatry 52:53-61, 2002b Goff DC, Henderson DC, Amico E: Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am J Psychiatry 149:1189-1194, 1992 Hall RG, Duhamel M, McClanahan R, et al: Level of functioning, severity of illness, and smoking status among chronic psychiatric patients. J Nerv Ment Dis 183:468-471, 1995

Hamera E, Schneider JK, Deviney S: Alcohol, cannabis, nicotine and caffeine use and symptom distress in schizophrenia. J Nerv Ment Dis 183:559-565, 1995

Hughes JR: Harm-reduction approaches to smoking: the need for data. Am J Prev Med 15:9-16, 1998

Hughes JR, Hatsukami DK, Mitchell JE, et al: Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 143:993-997, 1986 Hughes JR, Goldstein MG, Hurt RD, et al: Recent advances in the pharmacotherapy of smoking. JAMA 281:72-76, 1999 Ichikawa J, Ishii H, Bonaccorso S, et al: 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 76:1521-1531, 2001 Kelly C, McCredie RG: Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am J Psychiatry 156:1751-1757, 1999

Knable MB, Weinberger DR: Dopamine, the prefrontal cortex and schizophrenia.

J Psychopharmacol 11:123-131, 1997 Kumari V, Checkly SA, Gray JA: Effects of cigarette smoking on prepulse inhib-tion of the acoustic startle reflex in healthy male smokers. Psychopharmacol-ogy (Berl) 128:54-60, 1996 Kumari V, Soni W, Sharma T: Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry 156:1046-1051, 1999 Lasser K, Boyd JW, Woolhander S, et al: Smoking and mental illness: a population-based prevalence study. JAMA 284:2606-2610, 2000 Levin ED, Wilson W, Rose J, et al: Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15:429-436, 1996

Lichtermann D, Ekelund E, Pukkala E, et al: Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry 58:573-578, 2001 Light GA, Geyer MA, Clementz BA, et al: Normal P50 supression in schizophrenia patients treated with atypical antipsychotic drugs. Am J Psychiatry 157:767-771, 2000

Masterson E, O'Shea B: Smoking and malignancy in schizophrenia. Br J Psychiatry 145:429-432, 1984 McEvoy JP, Brown S: Smoking in first-episode patients with schizophrenia. Am J

Psychiatry 156:1120-1121, 1999 McEvoy J, Freudenreich O, McGee M, et al: Clozapine decreases smoking in patients with chronic schizophrenia. Biol Psychiatry 37:550-552, 1995a McEvoy J, Freudenreich O, Levin E, et al: Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology (Berl) 119:124-126, 1995b McEvoy JP, Freudenreich O, Wilson WH: Smoking and therapeutic response to clozapine in patients with schizophrenia. Biol Psychiatry 46:125-129, 1999 McGehee DS, Heath MJ, Gelber S, et al: Nicotinic enhancment of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269:16921696, 1995

Menza MA, Grossman M, Van Horn M, et al: Smoking and movement disorders in psychiatric patients. Biol Psychiatry 30:109-115, 1991

Meyer JM: Individual changes in clozapine levels after smoking. cessation: results and a predictive model. J Clin Psychopharmacol 21:569-574, 2001 Mortensen PB: Neuroleptic medication and other factors modifying cancer risk in schizophrenic patients. Acta Psychiatr Scand 75:585-590, 1987 Nagamoto HT, Adler LE, Waldo MC, et al: Gating of auditory P50 in schizophrenics: unique effects of clozapine. Biol Psychiatry 40:181-188, 1996 O'Farrell TJ, Connors GJ, Upper D: Addictive behaviors among hospitalized psychiatric patients. Addict Behav 8:329-333, 1983 Olincy A, Leonard S, Young DA, et al: Decreased bombesin peptide response to cigarette smoking in schizophrenia. Neuropsychopharmacology 20:52-59, 1999

Park S, Knopnick C, McGurk S, et al: Nicotine impairs spatial working memory while leaving spatial attention intact. Neuropsychopharmacology 22:200209, 2000

Parwani A, Duncan EJ, Bartlett E, et al: Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol Psychiatry 47:662-669, 2000 Pehek EA, Meltzer HY, Yamamoto BK: The atypical antipsychotic drug amper-ozide enhances cortical and striatal dopamine efflux. Eur J Pharmacol 240:107-109, 1993

Perry PJ, Miller DD, Arndt SV, et al: Haloperidol dosing requirements: the contributions of smoking and nonlinear pharmacokinetics. J Clin Psychopharmacol 13:46-51, 1993

Perry PJ, Bever KA, Arndt S, et al: Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram. Biol Psychiatry 44:733-738, 1998

Picciotto MR, Caldarone BJ, King SL, et al: Nicotinic receptors in the brain: links between molecular biology and behavior. Neuropsychopharmacology 22:451-465, 2000

Prochaska JO, DiClemente CC: Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 51:390-395, 1983

Regier DA, Farmer ME, Rae DS, et al: Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA 264:2511-2518, 1990 Saku M, Tokudome S, Ikeda M, et al: Mortality in psychiatric patients, with a specific focus on cancer mortality associated with schizophrenia. IntJ Epidemiol 24:366-372, 1995

Sandyk R: Cigarette smoking: effects on cognitive functions and drug-induced parkinsonism in chronic schizophrenia. Int J Neurosci 70:193-197, 1993 Seppala NH, Leinonen EV, Lehtonen ML, et al: Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients. Pharmacol Toxicol 85:244-246, 1999 Swerdlow NR, Caine SB, Braff DL, et al: The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications. J Psychopharmacol 6:176-190, 1992

Tsuang MT, Woolson RF, Fleming JA: Premature deaths in schizophrenia and affective disorders: an analysis of survival curves and variables affecting the shortened survival. Arch Gen Psychiatry 37:979-983, 1980 Tsuang MT, Perkins K, Simpson JC: Physical diseases in schizophrenia and affective disorder. J Clin Psychiatry 44:42-46, 1983 Vocci F, DeWit H (eds): NIDA/CPDD Consensus Statement on Evaluation of Outcomes for Pharmacotherapy of Substance Abuse/Dependence. Rockville, MD, National Institute on Drug Abuse, 1999 Weiner E, Ball MP, Summerfelt A, et al: Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia. AmJ Psychiatry 158:635-637, 2001 Williams GV, Goldman-Rakic PS: Modulation of memory fields by dopamine Dj receptors in the prefrontal cortex. Nature 376:572-575, 1995 Yassa R, Lal S, Korpassy A, Ally J: Nicotine exposure and tardive dyskinesia. Biol

Psychiatry 30:109-115, 1987 Zahrt J, Taylor JR, Matthew RG, et al: Supranormal stimulation of Dx receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17:8528-8535, 1997 Ziedonis DM, Kosten TR, Glazer WM, et al: Nicotine dependence and schizophrenia. Hosp Community Psychiatry 45:204-206, 1994 Ziedonis DM, George TP: Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophr Bull 23:247-254, 1997

Cigarette Crusher

Cigarette Crusher

Get All The Support And Guidance You Need To Permanently STOP Being A Slave To Nicotine And Cigarettes. This Book Is One Of The Most Valuable Resources In The World When It Comes To Easy Ways To Eliminate Smoking Addiction And Revitalize Your Body.

Get My Free Ebook


Post a comment